Project Description

Proximagen

Head Office – UK
Website(Owned by) www.upsher-smith.com
Client – FD (retiring)
Role
– FD
Practice – Search
Size – SME
Industry – Life Sciences

About

Proximagen is the drug discovery and development subsidiary of US-based Upsher-Smith Laboratories Inc, a fully-integrated pharmaceutical company whose mission is to deliver high-value, high-quality therapies and solutions that measurably improve patients’ lives. Located in Cambridge, UK, Proximagen has in-house capabilities in all core drug discovery disciplines, including medicinal chemistry, biology, drug metabolism and pharmacokinetics (DMPK). Proximagen is focused on developing small molecule therapeutics addressing a number of indications but primarily, diseases of the central nervous system.